Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16 books (23 items)

1.
Cognitive Aging: Progress in Understanding and Opportunities for Action.

Cognitive Aging: Progress in Understanding and Opportunities for Action.

Committee on the Public Health Dimensions of Cognitive Aging; Board on Health Sciences Policy; Institute of Medicine; Blazer DG, Yaffe K, Liverman CT, editors.

Washington (DC): National Academies Press (US); 2015 Jul 21.

2.
Diabetes Medications for Adults With Type 2 Diabetes: An Update [Internet].

Diabetes Medications for Adults With Type 2 Diabetes: An Update [Internet].

Bolen S, Tseng E, Hutfless S, et al.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Apr. (Comparative Effectiveness Reviews, No. 173.)

3.
Preventing Cognitive Decline and Dementia: A Way Forward.

Preventing Cognitive Decline and Dementia: A Way Forward.

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Committee on Preventing Dementia and Cognitive Impairment; Downey A, Stroud C, Landis S, et al., editors.

Washington (DC): National Academies Press (US); 2017 Jun 22.

4.
Evaluation Design for Complex Global Initiatives: Workshop Summary.

Evaluation Design for Complex Global Initiatives: Workshop Summary.

Board on Global Health; Institute of Medicine.

Washington (DC): National Academies Press (US); 2014 Jun 23.

5.
Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease.

Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease.

National Clinical Guideline Centre (UK).

London: National Institute for Health and Care Excellence (UK); 2014 Jul. (NICE Clinical Guidelines, No. 181.)

8.
Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation.

Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation.

Johnston R, Uthman O, Cummins E, et al.

Southampton (UK): NIHR Journals Library; 2017 Jan. (Health Technology Assessment, No. 21.2.)

10.
11.
12.
Screening for type 2 diabetes: a short report for the National Screening Committee.

Screening for type 2 diabetes: a short report for the National Screening Committee.

Waugh NR, Shyangdan D, Taylor-Phillips S, et al.

Southampton (UK): NIHR Journals Library; 2013 Aug. (Health Technology Assessment, No. 17.35.)

13.
Screening for Abnormal Glucose and Type 2 Diabetes Mellitus: A Systematic Review to Update the 2008 U.S. Preventive Services Task Force Recommendation [Internet].

Screening for Abnormal Glucose and Type 2 Diabetes Mellitus: A Systematic Review to Update the 2008 U.S. Preventive Services Task Force Recommendation [Internet].

Selph S, Dana T, Bougatsos C, et al.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Apr. (Evidence Syntheses, No. 117.)

14.
Diabetes (Type 1 and Type 2) in Children and Young People: Diagnosis and Management.

Diabetes (Type 1 and Type 2) in Children and Young People: Diagnosis and Management.

National Collaborating Centre for Women's and Children's Health (UK).

London: National Institute for Health and Care Excellence (UK); 2015 Aug. (NICE Guideline, No. 18.)

15.
Type 1 Diabetes in Adults: Diagnosis and Management.

Type 1 Diabetes in Adults: Diagnosis and Management.

National Clinical Guideline Centre (UK).

London: National Institute for Health and Care Excellence (UK); 2015 Aug. (NICE Guideline, No. 17.)

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center